Acute/relapsing experimental autoimmune encephalomyelitis: Induction of long lasting,antigen-specific tolerance by syngeneic bone marrow transplantation

Abstract

Experimental autoimmune encephalomyelitis (EAE) is an inducible autoimmune disease widely used as a model of the acute/relapsing stage of multiple sclerosis. We have previously shown that treatment of EAE-mice with high doses of cyclophosphamide (CY) (350 mg kg), followed by syngeneic bone marrow transplantation (SBMT), completely abrogates the clinical paralytic signs and even prevents the appearance of new relapses in the chronic-relapsing model of the disease. In the present study we examined whether this treatment protocol induces long term tolerance and whether this tolerance is antigen-specific. EAE was induced by immunization with spinal cord homogenate (MSCH) in complete Freund's adjuvant (CFA). The treatment with CY and SBMT was performed on day 6 post immunization. Treated and untreated mice were rechallenged with MSCH, or a non-relevant antigen (OVA) in CFA at various stages after the first paralytic attack. In contrast to previous data showing that animals recovering from acute EAE are usually refractory to re-induction of the disease, repeated injections of MSCH at different sites from the initial immunization, followed by i.v. injection of inactivated Bordetella bacteria, 2, 4 and 6 months after the initial EAE-induction, caused a severe and usually lethal relapse in all the untreated, control animals. Mice treated with CY and SBMT were resistant to all rechallenges with the same encephalitogenic inoculum. Following the second rechallenge, peripheral lymph node cells were examined in vitro for their proliferative responses to myelin antigens or to OVA. Lymphocytes obtained from CY+SBMT treated mice did not proliferate in vitro in response to myelin basic protein (MBP), but proliferated against OVA, when immunized with this antigen, after SBMT. Adoptive transfer of lymphocytes from tolerant mice to naive recipients did not transfer resistance to EAE-induction. Our results indicate that high doses of CY, followed by SBMT, induce long term antigen-specific tolerance presumably by a mechanism of clonal deletion or anergy.

Keywords

tolerance BMT EAE multiple sclerosis cyclophosphamide

Get full access to this article

View all access options for this article.

References

Raine C. (1984) Biology of disease. Analysis of auto-immune demyelination; Its impact upon Multiple Sclerosis . Labor Invest 50: 608-635 .

Hafler DA , Weiner HL. (1989) MS: a CNS and systemic autoimmune disease . Immunol Today 10: 104-107 .

Bernard CCA , Carnegie PR. (1975) Experimental auto-immune encephalomyelitis in mice: immunological response to mouse spinal cord and myelin basic protein . J Immunol 114: 1537-1540 .

Paterson PY. (1976) Experimental allergic encephalomyelitis induction, pathogenesis and suppression. In: Textbook of Immunopathology (eds Miescher PA , Mueller-Eberhard J ), p 179-179. New York, Grune and Straton .

Raine CS , Barnett LB , Brown A , Behar T , MFarlin DE. (1980) Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice . Lab Invest 43: 150-157 .

MacPhee IA , Mason DW. (1990) Studies on the refractoriness to reinduction of experimental allergic encephalomyelitis in Lewis rats that have recovered from one episode of the disease . J Neuroimmunol. 27: 9-19 .

Willenborg DO. (1979) Experimental allergic encephalomyelitis in the Lewis rat: studies on the mechanism of recovery from disease and acquired resistance to reinoculation . J Immunol 123: 1145-1150 .

Ben-Nun A , Ron Y , Cohen IR. (1980) Spontaneous remission of autoimmune encephalomyelitis is inhibited by splenectomy, thymectomy, and ageing . Nature 288: 389-390 .

Morton JI , Benjamin VS. (1979) Transplantation of autoimmune potential. Reversal of the NZB autoimmune syndrome by bone marrow transplantation . Transplantation 27: 133-134 .

10.

Ikehara S et al. (1985) Prevention of type I diabetes in nonobese diabetic mice by allogeneic bone marrow transplantation . Proc Natl Acad Sci 82: 7743-7747 .

11.

Himeno K , Good R. (1988) Marrow transplantation from tolerant donors to treat and prevent autoimmune disease in BXSB mice . Proc Natl Acad Sci 85: 2235-2239 .

12.

Theophilopoulos A. (1982) Role of the thymus in murine lupus and cellular transfer of the disease . Arthritis Rheumat 25: 726-733 .

13.

van Gelder M , Mulder AH , van Bekkum DW. (1996) Treatment of relapsing experimental autoimmune encephalomyelitis with largely MHC-matched allogeneic bone marrow transplantation . Transplantation 62: 810-818 .

14.

van Gelder M , van Bekkum DW. (1995) Treatment of relapsing experimental autoimmune encephalomyelitis in rats with allogeneic bone marrow transplantation from a resistant strain . Bone Marrow Transplant 16: 343-351 .

15.

Karussis DM et al. (1992) Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance with high dose cyclophosphamide followed by syngeneic bone marrow transplantation . J Neuroimmunol 39: 201-210 .

16.

Karussis DM et al. (1992) Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation . J Immunol 148: 1693-1698 .

17.

Karussis DM et al. (1993) Prevention and reversal of adoptively transferred chronic-relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplanation . J Clin Invest 92: 765-772 .

18.

Karussis DM et al. (1995) Immunomodulation of auto-immunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT) . Clin Exp Immunol 100: 111-117 .

19.

van Gelder M , van Bekkum DW. (1996) Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation . Bone Marrow Transplant 18: 1029-1034 .

20.

Van Gelder M , Kinwel-Bohre EP , Van Bekkum DW. (1993) Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT . Bone Marrow Transplant 11: 233-241 .

21.

Diebler GE , Martenson RE , Kies MW. (1972) Large scale preparation of MBP from central nervous tissue of several mammalian species . Prep Biochem 2: 139-165 .

22.

Ben-Nun A , Lando Z. (1983) Detection of autoimmune cells proliferating to myelin basic protein and selection of T-cell lines that mediate experimental allergic encephalomyelitis (EAE) in mice . J Immunol 130: 1205-1209 .

23.

Goodkin DE et al. (1995) Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis [see comments] . Ann Neurol 37: 30-40 .

24.

Ellison GW et al. (1988) Clinical experience with azathioprine: the pros . Neurology 38: 20-23 .

25.

Rudge P. (1988) Cyclosporine and multiple sclerosis: the cons . Neurology 38: 29-30 .

26.

Lisak RP. (1988) Overview of the rationale for immuno-modulating therapies in multiple sclerosis . Neurology 38: 5-8 .

27.

The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis . (1991) The Canadian Cooperative Multiple Sclerosis Study Group [see comments] . Lancet 337: 441-446 .

28.

Cook SD et al. (1986) Effect of total lymphoid irradiation in chronic progressive multiple sclerosis . Lancet 1: 1405-1409 .

29.

Staykova M , Goranov I , Nikolov T. (1978) L'influence Du cyclophosphamide sur le development de EAE . Ann Immunol 129: 415-427 .

30.

Rosenthale ME , Datko KJ , Kassarich L , Shneider F. (1969) Chemotherapy of experimental allergic encephalomyelitis (EAE) . Arch Int Pharmacodyn 179: 251-275 .

31.

Levine S , Sowinski R. (1977) Suppression of the hyperacute form of EAE by drugs . Arch Int Pharmacodyn 230: 309-318 .

32.

Slavin S et al. (1993) Immunohematopoietic reconstitution by allogeneic and autologous bone marrow grafts as a means for induction of specific unresponsiveness to donor-specific allografts and modified self in autoimmune disorders . Transplant Proc 25: 1274-1275 .

33.

Wood KJ. (1996) New concepts in tolerance . Clin Transplant 10: 93-99 .

34.

Burt RK , Burns W , Hess A. (1995) Bone marrow transplantation for multiple sclerosis [editorial] . Bone Marrow Transplant 16: 1-6 .

35.

Kazis A et al. (1996) Autologous blood stem cell transplantation in the treatment of multiple sclerosis . Eur J Neurol 3: 54-54 .

36.

McAllister LD , Beatty PG , Rose J. (1997) Allogeneic bone marrow transplant for chronic myelogenous leukemia in a patient with multiple sclerosis . Bone Marrow Transplant 19: 395-397 .

37.

Marmont AM. (1993) Immune ablation with stem-cell rescue: a possible cure for systemic lupus erythematosus? Lupus 2: 151-156 .

38.

Lowenthal RM , Cohen ML , Atkinson K , Biggs JC. (1993) Apparent cure of rheumatoid arthritis by bone marrow transplantation . J Rheumatol 20: 137-140 .